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The electroencephalogram (EEG) recorded from the
human scalp is widely used to study cognitive and brain
functionsinschizophrenia.Currentresearcheffortsarepri-
marilydevotedtotheassessmentofevent-relatedpotentials
(ERPs) and event-related oscillations (EROs), extracted
from the ongoing EEG, in patients with schizophrenia
and in clinically unaffected individuals who, due to their
family history and current mental status, are at high
risk for developing schizophrenia. In this article, we discuss
the potential usefulness of ERPs and EROs as genetic vul-
nerability markers, as pathophysiological markers, and
as markers of possible ongoing progressive cognitive and
cortical deterioration in schizophrenia. Our main purpose
is to illustrate that these neurophysiological measures can
offer valuable quantitative biological markers of basic
pathophysiological mechanisms and cognitive dysfunctions
in schizophrenia, yet they may not be speciﬁc to current
psychiatry’s diagnosis and classiﬁcation. These biological
markers can provide unique information on the nature
andextentofcognitiveandbraindysfunctioninschizophre-
nia. Moreover, they can be utilized to gain deeper theoret-
ical insights into illness etiology and pathophysiology and
may lead to improvements in early detection and more
effective and targeted treatment of schizophrenia. We con-
clude by addressing several key methodological, concep-
tual, and interpretative issues involved in this research
ﬁeld and by suggesting future research directions.
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Introduction
The electroencephalogram (EEG) recorded from the
human scalp provides a powerful noninvasive tool for
studying the brain mechanisms of attention and infor-
mation processing in health and disease.
1–7 In contrast
to blood flow neuroimaging techniques, such as magnetic
resonance imaging (MRI), the EEG provides a direct and
‘‘real-time’’ index of neuronal activities at a millisecond
scale of resolution that is relatively easy and inexpensive
to implement. Due to its high temporal resolution, the
EEG is ideally suited to examine the rapidly changing
patterns of brain activities that underlie human cognitive
function and dysfunction.
The scalp EEG is believed to reflect mainly the sum-
mated postsynaptic potentials from large synchronously
activated populations of pyramidal cells in the cerebral
cortex.
1–7 The recorded EEG activities show changes
over time, which are often rhythmic or oscillatory in the
sense that they alternate regularly. The rhythmic activities
in the resting or ‘‘spontaneous’’ EEG are usually divided
into several frequency bands (delta: <4 Hz; theta: 4–8 Hz;
alpha: 8–12 Hz; beta: 12–30 Hz; and gamma: 30–70 Hz
or higher, centered at 40 Hz), which are associated
with different behavioral states, ranging from sleep and
drowsiness to relaxation and heightened alertness and
mental concentration,
1,2,7,8 yet there exists little consen-
sus on the precise frequency limits of each band. The
EEG has a well-established value and role in the clinical
assessment, diagnosis, and management of patients with
certain neurological disorders, such as sleep disorders
and epilepsy.
7
TheEEGalsoshowssystematicchangeswhenaperson
processes a specific external or internal stimulus event,
such as a light flash or a sound or an internal thought.
In general, 2 types of changes temporally related to a sen-
sory, cognitive, or motor event may occur in the EEG
(figure 1).
9 One type of change involves the more tradi-
tional, well-examined event-related potentials (ERPs).
The other type of event-related EEG change is the
focus of more recent research efforts and variously
referred to as event-related synchronization and event-
related desynchronization,
9 event-related spectral pertur-
bation,
10 or event-related oscillations (EROs).
11–13
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955ERPs are a series of scalp-positive and -negative volt-
age deflections, waves, or components that are strictly
time and phase locked to the onset of a particular stim-
ulus event. ERPs can be extracted from the EEG by time
domain analysis and averaging the EEG activity follow-
ing multiple stimulus repetitions. The obtained ERPs
may be broadly subdivided into early or sensory-evoked
components (eg, auditory-evoked brainstem potentials,
P50, N100), which emerge within the first 50–100 ms
or so after stimulus onset and basically reflect stimulus
detection, and later or cognitive-related components
(eg, mismatch negativity [MMN], P300, N400), which
primarily index stimulus context.
3–6 While some of the
early sensory-evoked components are well established
as a clinical test to assess the integrity of the afferent
sensory pathways (eg, hearing, vision) of individual
patients,
7,14 the cognitive-related components reflect
more complex brain functions and have, to date,
mainly been utilized as a research tool instead of a clini-
cal tool.
EROs are changes in the frequency power spectrum of
the ongoing EEG, which can be either strictly time and
phase locked (evoked) or more loosely time-related and
non-phaselocked(induced)totheeliciting event.
15EROs
can be extracted by means of time-frequency domain
analysis and averaging the obtained EEG power spectro-
grams following the same stimuli. An important issue
awaiting clarification is whether ERPs reflect a transient
neural-evoked response that is added, but unrelated, to
the ongoing EEG oscillations, result from a reorgani-
zation or phase resetting of ongoing oscillations by a
given stimulus event, or are generated by a combination
of both or other mechanisms.
9–12,16 In general, it seems
that ERPs and EROs can give valuable complementary
insights into the basic mechanisms of cognitive and higher
brain functions, such as perception, attention, memory,
motor control, and language.
In this article, we discuss the application of ERPs and
EROs to the study of cognitive and brain functions in
schizophrenia. We focus on the results of more recent
studies of patients with schizophrenia as well as of clin-
ically unaffected persons who, by reason of their family
history and current mental status, are at high risk for
developing schizophrenia (for excellent reviews of older
EEG/ERP work on schizophrenia, see Zubin et al,
17
Pritchard,
18 and Friedman
19). We discuss selected ex-
amples of the potential usefulness of ERPs and EROs
as genetic vulnerability markers, as pathophysiological
markers, and as markers of possible ongoing progressive
cognitive and cortical deterioration in schizophrenia.
Our main purpose is to illustrate that these neuro-
physiological measures can offer valuable biological
markers of basic pathophysiological mechanisms and
cognitive dysfunctions in schizophrenia, yet they may
not be specific to current psychiatry’s diagnosis and
classification. These quantitative biological markers
can be utilized to gain deeper theoretical insights into
the etiology and pathophysiologyof complex and hetero-
geneous psychiatric disorders, such as schizophrenia,
and may lead to more accurate early detection and
more effective and targeted treatments.
20–27 We conclude
by addressing briefly several important methodo-
logical, conceptual, and interpretative issues involved
in this research field and by suggesting future research
directions.
Fig. 1. Five-level multiresolution decomposition of a human
averaged auditory event-related potential (ERP) based on the
discretewavelettransform(DWT),usingtheDaubechiesD5wavelet
as a mother wavelet. The application of a 5-level, dyadic DWT
decomposesthescalp-recordedevent-relatedelectroencephalogram
(EEG) signal (upper panel) in the time-frequency plane at
different resolution levels, or scales, into a set of basic orthogonal
individual signal components (lower panels) that approximately
correspond to the main rhythmic activities traditionally used to
classify the ongoing EEG. The result of the DWT yields 5 detail
functions and corresponding sets of wavelet detail coefficients
(D1–D5),representingtheenergyoftheEEGsignalasafunctionof
time in the 63- to 125-Hz (D1, gamma), 31- to 63-Hz (D2,
gamma),16-to31-Hz(D3,beta),8-to16-Hz(D4,alpha),and4-to8-
Hz (D5, theta) frequency bands, and one final set of wavelet
approximation coefficients (A5), representing the activity of the
remainingpartofthesignalinthe0-to4-Hz(delta)frequencyband.
Notethatthefrequencybandlimitsareroundedandthatthey-axisis
scaled differently for each frequency band. By applying the inverse
DWT, the detail (D1–D5) and approximation (A5) signal
components,aswellastheoriginalsignal(ERP 5 A5þD5þD4þ
D3 þ D2 þ D1), can be reconstructed from the wavelet coefficients
for each scale.
184,189 The ERP was recorded at the midline central
scalp electrode from a healthy adult subject in response to task-
irrelevantfrequentstandard1000-Hztones(100-msduration,10-ms
rise/fall, using a variable interstimulus interval of 1300–1700 ms),
whilethesubjectperformedavisualoddballtask.Thedataindicate
that the auditory ERP (upper panel) coincides with auditory
transient-evoked (phase locked) oscillations in multiple frequency
bands (lower panels), including early evoked gamma (31–63 Hz)-
bandresponsesthatpeakaround20and60ms andanearlyevoked
beta (16–31 Hz)-band response that peaks around 30 ms after
tone onset.
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A variety of ERPs and EROs have been examined in
schizophrenia, including the auditory-evoked P50 ‘‘sen-
sory gating’’ response.
6,25,27,28 Here, we select to consider
the P300, MMN, and EROs in the gamma-band fre-
quency range, referred to as the gamma-band response
(GBR), as biological markers of potentially distinct path-
ophysiological mechanismsand cognitivedysfunctions in
schizophrenia.
P300 as a Vulnerability Marker
A vulnerability marker, or endophenotype,
24 may be
defined as ‘‘a heritable trait, associated with a causative
pathophysiological factor in an inherited disease.’’
20 A
vulnerability marker may be distinguished from a risk
factor, which refers to any characteristic that has predic-
tive validity, but not etiological significance, for develop-
ing a psychiatric disorder.
29 Thus, in theory, while both
can be used to predict psychiatric disease, only a vulner-
abilitymarker can offer basicinsights into illness etiology
and pathophysiology and may contribute to the rational
development of psychiatric diagnostic systems and ther-
apeutic treatments that are based on the underlying ill-
ness causes and biology rather than on the final overt
complex clinical phenotypes.
20–27
Basic Studies. The P300 (P3 or P3b) refers to a late
scalp-positive ERP component that is usually recorded
inanauditoryorvisual‘‘oddball’’experimentalparadigm
in which a subject detects an infrequent deviant or task-
relevant ‘‘target’’ stimulus (eg, a 1000-Hz tone) randomly
presented within a series of frequent nontarget or ‘‘stan-
dard’’ stimuli (eg, 1500-Hz tones).
30–33 The size or ampli-
tude of the P300 elicited by task-relevant target stimuli
is typically largest over the medial central and parietal
scalp locations, and its peak latency, depending on stim-
ulus, task, and subject factors, may occur between about
300 and 1000 ms after stimulus onset. The P300 is a rela-
tively slow, low-frequency neuroelectrical event and
linkedtostimulus-evokeddeltaandthetaoscillations.
13,34
The P300 is believed to index stimulus significance and
the amount of attention allocated to the eliciting stimulus
event, being maximal to task-relevant or attended stimuli
and being absent or small to task-irrelevant or unat-
tended stimuli.
31–33,35 While the P300 reflects primarily
cognitive factors, this component can also be sensitive
to constitutional factors (eg, age, sex) and to natural
(eg, circadian rhythm, menstrual cycle) and environmen-
tally induced (eg, exercise, caffeine, nicotine, psychotro-
pic medications) changes in the subject’s arousal
state.
33,35,36 Similarly, the P300 can be sensitive to indi-
vidual differences in major personality trait dimensions,
such as sensation seeking or novelty seeking.
37,38
The intracerebral origin of the P300 is poorly under-
stood but most likely involves the complex summation
of activity from multiple brain regions, particularly
the various association areas of the cerebral cortex and
the limbic system.
32,39–41 Similarly, the neurochemical
substratesoftheP300areunclearbutpresumablyinvolve
various neurotransmitter systems in the brain.
32,42 The
P300 most likely reflects the summation of multiple,
simultaneously occurring cognitive and brain processes
39
that are engaged during the active processing of behav-
iorally significant stimulus events and functionally linked
to attentional resource allocation and memory updating
operations in the brain.
31,33,36,40,43
Genetically,theP300isconsideredmultifactorialanda
complex quantitative trait. Family and twin studies have
indicated that P300 characteristics are heritable,
26,44–50
but reported heritability estimates vary greatly (ranging
between about 0.3 and 0.7) as a function of experimental
task paradigm, P300 measure (eg, amplitude vs latency),
scalp location (eg, frontal vs parietal), stimulus type
(eg, target vs nontarget), stimulus modality (eg, visual
vs auditory), age, and sex. Information about the molec-
ular genetic basis of P300 is thus far limited and comes
mostly from psychiatric genetic research, which will be
discussed later.
Clinical Studies. Numerous studies have shown that
schizophrenia patients display a smaller than normal
auditory P300 over the midline central and parietal scalp
electrode locations,
17,18,44,47,50–57 as well as a distinct left-
smaller-than-right voltage asymmetry at temporal scalp
sites.
58–65 Auditory P300 amplitude abnormalities over
the posterior scalp have been detected in schizophrenia
patients at the initial and advanced stages of illness
60,64,65
and remain detectable even in patients free of clinical
symptoms and in relative remission.
55 Additionally,
schizophrenia patients often show a prolonged auditory
P300 latency relative to healthy control subjects.
50,56,57
Schizophrenia patients have also been found to gener-
atea significantly smaller and/or delayed visual P300over
the posterior scalp than healthy control subjects,
56 but
this finding seems less robust
55 and the size of patient-
control group differences is usually smaller.
56,63 As com-
pared with the auditory P300, the visual P300 in schizo-
phrenia seems more sensitive to clinical state variables,
such as current antipsychotic medication status and clin-
ical symptom severity.
53,55 Accordingly, it has been sug-
gested that the visual P300 could serve primarily as a
clinicalstatemarker,whereastheauditoryP300couldoffer
a trait or vulnerability marker of schizophrenia.
18,52,53,55,63
Additional supporting evidence for the idea that the au-
ditoryP300indexesageneticandbiologicalvulnerabilityto
schizophreniahascomefromseveral,thoughnotall,
19,61,66
family-based ‘‘high-risk’’ studies showing that this ERP
component is also impaired in clinically unaffected family
members who, by reason of their family history, are at
high risk for developing schizophrenia.
44,47,50,67 Similarly,
persons with either psychometrically
68 or clinically
69,70
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EEG in Schizophreniadefined schizotypal personality traits, who are assumed
to carry the same latent vulnerability as schizophrenia
patients,
71–73 display P300 amplitude abnormalities.
Similarly, we recently observed that auditory P300 am-
plitude abnormalities over the posterior scalp, similar to
those detected under identical experimental conditions in
recently ill and chronically ill schizophrenia patients, are
present in putatively ‘‘prodromal’’ patients who, on the
basis of both their family history and current mental sta-
tus,
74 are at ultrahigh risk for developing a first psychotic
episode (figure 2).
64 Longitudinal follow-up data and large
patientsamples,however,arerequiredtodeterminewhether
the auditory P300 has indeed predictive validity for later
schizophrenia or other psychiatric disorders in these
ultrahigh-risk populations. An earlier family-based longitu-
dinal prospective study reported that both the auditory
and visual P300 recorded from adolescent subjects, irre-
spective of their family history risk status, has predictive
validity, not for a diagnostically specific psychiatric out-
come but for later global behavioral maladjustment in
general.
75
The auditory and visual P300 seem to be impaired
not only in schizophrenia but in a variety of psychiatric
and neurological disorders, including bipolar affective
disorder, attention-deficit hyperactivity disorder, and
substance use disorders.
19,26,32,33,52,76–86 In particular,
impaired generation of the visual P300 has been found
to characterize individuals with alcoholism as well as
clinically unaffected family members, such as children
of alcoholics, who are at high genetic risk for developing
alcoholism.
26,76,77,80–85 Longitudinal follow-up data
from this and related research fields indicate that the
visual P300 recorded from children and adolescents,
regardless of their family history risk status, has predic-
tive validity, not specifically for alcoholism but more
generally for a spectrum of ‘‘disinhibitory’’ behavioral
syndromes, including childhood externalizing disorders
and adult antisocial personality disorder and substance
abuse.
81,85,86
Relatively little is yet known about the molecular
genetic bases of the P300 and of its disruption in schizo-
phrenia. Blackwood et al
67 reported that within a large
Scottish family, a translocation breakpoint region on
chromosome 1q42 shows evidence for linkage to schizo-
phrenia as well as to unipolar and bipolar affective dis-
orders and that translocation carriers, either clinically
20
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Fig. 2. Group mean event-related potentials (ERPs) elicited by
auditorytargetstimulirecordedatmidlinefrontal(Fz),central(Cz),
and parietal (Pz) scalp locations, superimposed for subjects at high
riskfor schizophrenia (n 5 10; meanage 5 22.1years, SD 5 4.3),
subjectswithrecent-onsetschizophrenia(n 5 10;meanage 5 21.3
years, SD 5 3.2; mean illness duration 5 0.6 years, SD 5 0.3),
subjects with chronic schizophrenia (n 5 14; mean age 5 37.5
years, SD 5 7.5; mean illness duration 5 12.2 years, SD 5 6.8),
young healthy control subjects (n 5 14; mean age 5 22.5 years,
SD 5 2.0) who are age matched to the high-risk and recent-onset
groups, and older healthy control subjects (n 5 14; mean
age 5 34.1 years, SD 5 10.9) who are age matched to the chronic
patientgroup.TheERPswerecollectedwhilesubjectsperformedan
auditory oddball task. The auditory stimuli were pure sinusoidal
tones (100-ms duration, 10-ms rise/fall), consisting of frequent
standard stimuli (1000-Hz tones, P 5 91.5%) and infrequent
deviant or target stimuli (1064-Hz tones, P 5 8.5%), presented
binaurally through inserted earphones in a random order using
aconstantinterstimulusintervalof1500ms.Studyparticipantswere
instructed to pay attention to the auditory stimuli and to make
a button-press response only to the infrequent target stimuli,
emphasizing both speed and accuracy. P300 refers to the late
scalp-positive ERP component associated with target detection.
High-risk, recent-onset, and chronic schizophrenia patient groups
all showed significantly smaller P300 amplitudes at Pz and/or Cz
relative to healthy age-matched control subjects. Older healthy
control subjects displayed significantly smaller P300 amplitudes at
Pzcomparedwithyoungerhealthycontrolsubjects.Reprintedwith
permission from Schizophr Res.,
64 Copyright 2005, Elsevier.
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O. van der Stelt and A. Belgeraffectedornot,exhibitauditoryP300abnormalities.This
chromosomal site harbors 2 recently described genes la-
beled ‘‘Disrupted In Schizophrenia 1 and 2’’ (DISC1 and
DISC2), which seem to be involved in both early brain
development and adult neurogenesis and neural plastic-
ity.
87,88 Additionally, a significant association has been
observed in schizophrenia patient and healthy subject
populations between the auditory P300 and catechol-
O-methyltransferase (COMT) genotype,
89,90 a gene
that also has been implicated in schizophrenia
vulnerability,
87,88 but another study failed to observe a
significant association between the auditory P300 and
COMT polymorphism.
91
Genetic linkage analyses of data from the Consortium
on the Genetics of Alcoholism (COGA), a large, multi-
center family-based study, have yielded several chromo-
somal regions, in particular on chromosomes 2, 4, 5, 6,
13, and 17, that appear to be linked to the visual P300
amplitude.
26,48,49 The chromosomal regions linked to
the visual P300 each contain many genes, including those
encoding glutamate and acetylcholine receptors, and
usually show also linkage, though in a wider region of
linkage, to clinical diagnoses of alcoholism and related
disorders.
92 The reported linkage of the visual P300
amplitude to an area on chromosome 5 is noteworthy
because this region has also been implicated in schizo-
phrenia
93 and contains the Engrailed-1 gene(En1), which
codes for a protein that is brain expressed and implicated
in neuronal differentiation.
94
Furthermore, COGA has reported both linkage and
association between visual-evoked theta and delta oscil-
lations accompanying the visual P300 generation and
a muscarinic cholinergic receptor M2 gene (CHRM2)
on chromosome 7.
95 While variants within or close to
the CHRM2 locus have also been found to influence
riskforalcoholismandmajordepressivedisorder,
96these
findings suggest that central muscarinic acetylcholine
receptorsystemsinfluencethegenerationofevent-related
theta and delta neuronal oscillations associated with the
P300 and with basic cognitive and memory functions in
healthy subjects.
13,97 These findings may have relevance
to the visual P300 abnormalities observed in schizophre-
nia because central muscarinic acetylcholine receptor
abnormalitieshavealsobeenimplicatedinthepathophys-
iology and cognitive dysfunction of schizophrenia.
98,99
Conclusion. The visual and auditory P300 seem to be
impairednotonlyinschizophreniabutinavarietyofpsy-
chiatric disorders characterized by cognitive and brain
dysfunction. Initial data from psychiatric genetic studies
similarly suggest that the putative genes (eg, DISC1,
COMT, CHRM2) that underlie these neuroelectrical
measures are not diagnostically specific and are
involved, to a lesser or greater extent, in multiple psychi-
atric clinical phenotypes. These findings suggest that
P300 abnormalities detected over the posterior scalp
in schizophrenia reflect a more general biological and
cognitive vulnerability or risk factor that cuts across cur-
rent psychiatric diagnostic categories. Conceivably, the
actual behavioral outcome in any particular individual
carrying this vulnerability depends on other genetic and
environmental factors specific to the individual.
37,72,75–77
This interpretation does not preclude the possibility that
the P300 also reflects, in its scalp topography or sub-
components, other or more diagnostically specific illness
pathology,
100 such as the left-smaller-than-right temporal
scalp voltage asymmetry often observed in schizophrenia
patients.
58–65
In addition, evidence is emerging that P300 can be uti-
lized successfully as an intermediate phenotype in identi-
fying clinically unaffected vulnerability-gene carriers
26,67
and, hence, increasing the power of genetic linkage and
association studies of complex psychiatric disorders.
92
From a clinical perspective, the P300 while unlikely pro-
viding a diagnostically specific marker of risk could be-
come useful for the early detection and prediction of
psychopathology in general. It remains to be determined,
however, whether P300 represents a risk factor or truly
a vulnerability marker that is causally related to later
manifestation of psychopathology. Furthermore, several
other key conceptual and methodological issues remain
to be addressed, which will be considered later.
MMN as a Marker of Possible Progressive Pathology
Current theories about the origin of schizophrenia pos-
tulate that not only early neurodevelopmental processes
but also later progressive, perhaps neurodegenerative,
processes are involved in the etiology and pathogenesis
of the illness.
101–106 The possibility has recently been
raised that the MMN component of the ERP could offer
a biological marker of postonset progressive cognitive
and cortical deterioration in schizophrenia.
107,108 If
empirically validated, the MMN could have profound
theoretical and clinical implications for understanding
and treating schizophrenia.
Basic Studies. The MMN refers to a scalp-negative
ERP component that is usually recorded in a ‘‘passive’’
auditory oddball paradigm.
3,109–112 In this paradigm,
subjects passively listen to a series of frequent standard
and infrequent deviant auditory stimuli while they are
resting or are involved in the attentive processing of
visual information, such as reading a book or performing
a visual discrimination task. The MMN typically occurs
between about 100 and 250 ms following the infrequent,
physically deviant auditory stimuli and reaches maximal
voltages over frontal and central scalp locations. Al-
though this ERP component may be affected by subject’s
attention in certain situations,
113,114 the MMN is essen-
tially an automatic, preattentive brain response because
its generation is not dependent on the subject’s atten-
tion toward the eliciting deviant auditory stimuli.
3,109–112
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EEG in SchizophreniaHuman and animal studies suggest that the MMN is gen-
erated primarily within the supratemporal plane in or
near the primary auditory cortex, with possible addi-
tional generating sources in the frontal lobe.
3,109–117
The MMN is believed to reflect a ‘‘mismatch’’ or com-
parison process between the current deviant acoustic in-
put and a neuronal sensory memory trace representing
the physical features of the preceding standard stim-
uli.
3,109,110,112 The MMN represents the initial processing
step in a biologically important series of cognitive and
brain events involved in alerting and redirecting the
organism’s attention toward novel or deviant, potentially
significant, auditory stimulus events in the environment.
Because the MMN provides a unique objective measure
of auditory discrimination and sensory memory, this
component offers a powerful research tool for basic
cognitive neuroscience as well as for clinical and other
applications.
3,109–120
Clinical Studies. Shelley et al
121 were the first to report
that the MMN elicited by a deviation in tone duration is
substantially reduced in chronically ill, medicated schizo-
phreniapatients.Since thenmanystudies haveconfirmed
that MMN responses elicited by a change in tone dura-
tion as well as in tone frequency are often markedly re-
duced in chronic schizophrenia patients as compared
with healthy control subjects.
54,65, 107,108,116,122–128 The
MMN amplitude deficits seen in chronic schizophrenia
patients seem to parallel deficits in tone-matching perfor-
mance
122 and do not seem to be affected by antipsychotic
medications.
108 Moreover, MMN deficits appear to be
relatively specific to schizophrenia in that they are not
prominent features of unipolar and bipolar affective dis-
orders.
126 Abnormalities of MMN, however, have also
been observed in dyslexia,
129 as well as in normal aging
and in various neurological disorders,
130 although the
observed patterns of MMN deficits in these conditions
appear to be different than the pattern seen in chronic
schizophrenia.
Additionally, impaired MMN generation in chroni-
cally ill schizophrenia patients is associated with higher
order cognitive deficits
54 and global impairments in
social and everyday functioning
127,128 but generally
does not show a consistent relationship to clinical symp-
toms.
108 Moreover, schizophrenia-like deficits in MMN
generation can be experimentally induced in nonhuman
primates following either systemic or local infusion of
N-methyl-D-aspartate (NMDA) antagonists directly in
the auditory cortex,
116 as well as in healthy humans fol-
lowing administration of the NMDA receptor antagonist
ketamine,
131 supporting recent glutamate/NMDA path-
ophysiological theories of schizophrenia.
87,88,116,132,133
The genetics of MMN are as yet poorly understood. It
has been reported that the tone duration–deviant MMN
is smaller thannormal, notonly in schizophreniapatients
but also in clinically unaffected biological relatives,
123
but another family study was unable to confirm the latter
finding.
134 MMN abnormalities similar to those seen in
schizophrenia have been found in adolescents and young
adults with 22q11 deletion or velocardiofacial syndrome,
which is associated with markedly elevated rates of major
psychiatric disorders, including schizophrenia, in early
adulthood, with COMT polymorphism modifying the
severity of MMN abnormalities in this syndrome.
135
Thesefindingsseemtoimplicatethatgeneticallymediated
alterations of catecholaminergic, especially dopaminer-
gic,neurotransmissioncontributetoMMNabnormalities
and elevated neuropsychiatric risk in this syndrome.
However, a study of twin pairs discordantfor schizophre-
nia reports that MMN amplitudes are smaller than
normal in schizophrenia patients but are normal in
theirunaffectedco-twins,
136suggestingthatMMNabnor-
malities reflect state rather than trait characteristics of
schizophrenia.
Cross-sectional studies of schizophrenia patients at
the initial and advanced stages of illness suggest that
MMN abnormalities are present selectively or predomi-
nantly in chronically ill patients, whereas recently ill and/
or first-episode patients display MMN potentials that do
not differ markedly from those recorded in healthy age-
matchedcontrolsubjects.
63,65,107Similarly,inaccordance
with the findings of a recent study,
137 we observed that
putatively prodromal patients at high imminent risk
for developing a first psychotic episode exhibit, as a
group, tone frequency–deviant MMN responses that
do not differ significantly from those seen in healthy
age-matched control subjects (figure 3), while marked
differences between these 2 groups existed in the auditory
P300 (figure 2).
Moreover, a recent meta-analysis of MMN in
schizophrenia
108 reports that the effect size of patient-
control group differences in the MMN elicited by
a change in tone frequency as well as in tone duration
shows significant positive correlations with illness dura-
tion (both r > 0.67, P = 0.05). Although all studies in-
cluded were limited by utilizing cross-sectional, and
not longitudinal, designs, these observations raise the
possibility that MMN impairments in schizophrenia
do not reflect trait and premorbid deficits but develop
over time and index postonset progressive cognitive
and cortical deterioration in the illness.
107,108 Indeed,
preliminary longitudinal follow-up data suggest that
MMN, at least elicited by tone frequency–deviant stimuli
and at the overall group level of analysis, is not impaired
at first hospitalization for schizophrenia but declines
significantly during the early course of the illness, paral-
leling MRI-based measures of perionset progressive gray
matter loss within the left auditory cortex of these
patients.
138
Alternatively, incorporating the possibility that MMN
partially reflects also trait and premorbid features of
schizophrenia,
65,123 MMN is impaired at illness onset
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O. van der Stelt and A. Belgerandindexesprogressivepathologybutonlyinasubgroup
ofrecentlyillschizophreniapatientswhohavepreexisting
neurocognitive deficits and/or go on to have a less favor-
able outcome and a chronic course of illness.
65
Conclusion. Chronically ill schizophrenia patients seem
to exhibit not only high-level attention–dependent cogni-
tiveprocessingdeficits,asindexedbyP300abnormalities,
but also preattentive deficits in auditory discrimination
at the initial level of the auditory cortex, as manifested
by MMN abnormalities. Because MMN abnormalities
observed in schizophrenia appear to be sensitive to
premorbid cognitive status
65 and family history risk sta-
tus,
123 as well as being much more dominant in chroni-
cally ill patients than in recently ill or first-episode
patients,
63,65,107,108 these abnormalities have been hypo-
thesized to reflect both premorbid or trait characteristics
ofschizophreniaandpostonsetprogressiveillnesspathol-
ogy in brain regions mediating auditory perception and
language processing. On this view, the MMN could offer
a unique clinical tool that helps to develop and monitor
therapeutic interventions aimed at halting, delaying, or
even preventing putative progressive cortical and cogni-
tive deterioration in schizophrenia.
Several critical issues, however, remain to be addressed
before any conclusions about the MMN in schizophrenia
can be drawn with confidence. As already indicated
above, longitudinal prospective studies are required to
determine whether the severity of MMN abnormalities
truly increases across the preonset, recent-onset, and
chronic stages of schizophrenia. Longitudinal follow-
up MRI data suggest that temporal lobe cortical struc-
tures involved in MMN generation, as well as frontal
and other brain regions, do show ongoing progressive
volume reductions during the early stages of schizophre-
nia, initiating prior to or around the initial manifestation
of full-blown psychotic symptoms.
139–141
Additionally, several studies have reported that MMN
potentials recorded at the frontal, but not at the tempo-
ral, scalp electrode locations are impaired in chronic
schizophrenia patients.
124,125 These observations have
been interpreted as indicating that the hypothesized fron-
tal generating sources of MMN involved in behavioral
orienting, rather than the preattentive sensory mismatch
detectors in auditory cortex, are compromised in schizo-
phrenia. Alternatively, the dissociation of MMN at fron-
tal vs temporal sites could reflect impaired coactivation
or functional ‘‘disconnection’’ of the temporal and fron-
tal cortical regions involved in auditory change detection
and orienting.
125 To disentangle possible temporal and
frontal contributions to MMN abnormalities in schizo-
phrenia, detailed topographic studies are required that
record the MMN at many scalp electrodes and utilize ad-
vanced signal spatial enhancing methods and anatomical
MRI-based information from each study participant in
an effort to correct the distortion due to volume conduc-
tionofMMNsignalsthroughtheskullandscalp.
2–7,9,10,142
GBR as a Pathophysiological Marker
Event-related neuronal oscillations in the gamma-band
frequencyrange(GBRs)arehypothesizedtobefundamen-
tal to normal brain function and cognition
12,13,15,143–149
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Fig. 3. Group mean event-related potential (ERP) difference
waveforms, formed by subtracting the ERPs to auditory standard
stimuli from the ERPs to auditory deviant stimuli, recorded at
midline frontal (Fz) andcentral (Cz) scalp locations, superimposed
forsubjects athighriskfor schizophrenia(n 5 9;meanage 5 21.9
years, SD 5 4.5) and healthy age-matched control subjects
(n 5 10; mean age 5 21.9 years, SD 5 3.5). The ERPs were
collected using a passive auditory oddball paradigm while subjects
performed a visual oddball task. The auditory stimuli were pure
sinusoidal tones (100-ms duration, 10-ms rise/fall), consisting of
frequent standard stimuli (1000-Hz tones, P 5 97.1%) and
infrequent deviant stimuli (1064-Hz tones, P 5 2.9%), presented
binaurally through inserted earphones in a random order using
a variable interstimulus interval (ISI) of 1300–1700 ms. The visual
stimuli were pictures, consisting of frequent standard stimuli
(squares), infrequent novel stimuli (unique familiar objects), and
infrequentdeviantor targetstimuli(circles), andwerepresentedon
acomputerscreeninarandomorderusingaconstantISIof1500ms.
Study participants were instructed to pay attention to the visual
stimuli, while ignoring the auditory stimuli, and to make a button-
press response only to the infrequent visual target stimuli,
emphasizing both speed and accuracy. Mismatch negativity
(MMN) refers to the mismatch negativity ERP component
associated with auditory change detection. MMN peak latency,
peak amplitude, and mean amplitude across the 100- to 250-ms
poststimulus latency range did not differ significantly between
groups(eg,MMNatFz,high-riskvscontrol:peaklatency172627
msvs191636ms,t 5 1.3,P>0.22;peakamplitude-4.361.4lVvs
-5.362.0lV,t 5 1.3,P>0.22;meanamplitude,-2.460.8lVvs-
2.5 6 1.1 lV, t 5 0.2, P > 0.82). Unpublished data from subjects
participating in an earlier study from our laboratory.
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EEG in Schizophreniaand to their disruption in schizophrenia.
150–152 Accord-
ingly, the study of GBRs holds promise of unraveling a
basic pathophysiological mechanism mediating wide-
spreadcognitivedysfunctionin schizophrenia. Moreover,
research into their underlying neuronal generating mech-
anisms could lead to pathophysiologically based treat-
ment interventions in schizophrenia,
152,153 even if
GBRs merely index a ‘‘final common pathway’’
154 or
set of molecular and cellular alterations that are geneti-
cally and etiologically heterogeneous and downstream
consequences of the primary pathogenic process in the
illness.
133,155
Basic Studies. Recent basic cognitive neuroscience
studies suggest that gamma oscillations and their en-
hancement and phase synchronization during infor-
mation processing play a key role in a wide variety of
cognitive and brain functions in animals and
humans.
12,13,15,143–149,153 GBRs have been observed dur-
ing various types of information processing across sen-
sory modalities and across species and at multiple
levels of spatial analysis, from microscopic (eg, single
unit) to macroscopic (eg, scalp EEG) measurements.
According to Galambos,
156 3 types of GBRs may be dis-
tinguished: firstly, the steady-state–evoked GBR to
repetitive stimulation at different frequencies; secondly,
the transient-evoked GBR that is phase locked to the
onset of a transient stimulus; and lastly, the induced
GBR that is not phase locked to stimulus onset. It is
generally assumed that evoked GBRs primarily index
sensory processing and reflect cortical responses due to
changes in afferent activity, whereas induced GBRs are
cognitive in nature and generated by changes in func-
tional connectivity within neuronal networks.
9,15,157
While stimulus-evoked GBRs are linked to sensory pro-
cessing, they can be modulated by top-down attentional
influences.
158,159 Little is as yet known about the genetics
of GBRs. A recent study reports significant associations
of human auditory-evoked and induced GBRs with
genetic polymorphisms of the dopamine receptor D4
(DRD4) and dopamine transporter (DAT1) but not
with COMT polymorphism.
160
Currently dominant theories hypothesize that stimulus-
induced GBRs reflect the dynamic integration or tem-
poral ‘‘binding’’ of spatially distinct neuronal activities
withinandbetweenbrainregionstoenabletheemergence
of coherent perception, thinking, and action.
12,15,143–149
According to this view, induced GBRs reflect the opera-
tion of a fundamental brain integrative mechanism that
counterbalancesthedistributedanatomicalandfunctional
organization of brain activity and are involved in a wide
range of cognitive functions, such as sensory discrimina-
tion, perception, selective attention, working memory,
sensory-motor integration, and motor control. It has
been suggested that, while the fast gamma oscillations
seem to be most clearly involved in neural synchrony,
they ultimately have to be understood in the context of
theslower, lower frequencies (eg,beta,alpha, theta)as dif-
ferent frequencies could dynamically interact with each
other (eg, gamma-to-beta transitions, multifrequency syn-
chrony) and could reveal different dimensions or aspects
of the hypothesized brain integration processes.
13,149,161
The neuroanatomy and neurophysiology of GBRs are
complex and not yet fully understood. Animal and hu-
man studies indicate that GBRs are locally generated
in many areas of the brain,
12,148,149,153,156–159 including
the hippocampus and cerebral cortex, suggesting that
these neuronal responses are not unitary brain events as-
sociated with a specific sensory or cognitive process, such
as temporal binding, but involve a wide variety of ana-
tomically and functionally distinct types of GBRs.
13
The cellular mechanisms of GBRs are believed to involve
networks of gamma-aminobutyric acid (GABA)ergic
interneurons that are driven both by phasic synaptic
excitation and inhibition and by electrical coupling be-
tween interneuron dendrites and between pyramidal
cell axons.
153,162,163 Synchronization of gamma activity
within such networks of inhibitory interneurons is
thought to propagate downstream in cortical microcir-
cuits synchronizing pyramidal cell firing and enabling
coherent cortical information processing. The combina-
tion ofGABAergic synapticand electrical couplingcould
represent a general mechanism for the synchronization of
neuronal population activity in a variety of brain regions
and structures.
ClinicalStudies. Severalstudieshaveshownthatschizo-
phrenia patients display reduced power and phase syn-
chronization of steady-state auditory-evoked GBRs to
clicks, tonepips, oramplitude-modulatedtonespresented
at 40 Hz but not at lower rates of stimulation.
164–167 A
slowerbuildupofsteady-statevisual-evokedpotentialam-
plitudes following stimulus onset has also been reported
in schizophrenia,
168 as well as a significant relationship
between the latency of the steady-state visual-evoked
potential and auditory hallucinations in schizophrenia
patients.
169 Another study found no significant overall
patient-control group differences but reported that
steady-state auditory-evoked GBRs are markedly en-
hanced in schizophrenia patients taking new generation
or atypical antipsychotic medications as compared with
patients on conventional or typical antipsychotics.
170
Results have been mixed as to whether the deficits ob-
served in schizophrenia patients are also present in per-
sons with schizotypal personality traits.
165,170
Additionally, early auditory transient-evoked GBRs,
which typically are maximal over the centrofrontal scalp
and emerge within the first 50 ms following stimulus on-
set, have been reported to be reduced in power in schizo-
phrenia patients relative to healthy control subjects,
171
but other studies detected no significant deficits in early
auditory-evoked GBRs in schizophrenia patients.
172,173
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O. van der Stelt and A. BelgerAlso, we recently observed little or no significant abnor-
malities in the latency, power, and degree of intertrial
phase locking of early auditory transient-evoked GBRs
to task-irrelevant pure tones in high-risk, recent-onset,
and chronic schizophrenia patients, nor were abnormal-
ities observed in the simultaneously occurring auditory-
evoked P50, N100, and P200 potentials of the broadband
ERPs (O. van der Stelt and A. Belger, unpublished data).
Severalstudieshavefoundthattheintegrityofstimulus-
evoked GBRs in schizophrenia patients varies accord-
ing to the nature and severity of their current clinical
symptoms. Reduced auditory-evoked GBRs have been
noted in nonparanoid, but not in paranoid, schizophre-
nia subtypes.
174 Similarly, increased levels of clinical neg-
ative symptoms in schizophrenia patients seem to be
associated with diminished auditory-evoked GBRs,
whereas increased positive symptoms are associated
with enlarged auditory-evoked GBRs.
159,175 Moreover,
exceptionally large gamma-band rhythms have been
measured simultaneously during the occurrence of so-
matic hallucinations in a schizophrenia patient.
176
Furthermore, it has been demonstrated that patients
with schizophrenia exhibit impaired phase locking and
phase coherence, along with normal power, of early
visual transient-evoked GBRs over the occipital scalp
during the perception of visual Gestalt patterns,
177 sug-
gesting that the temporal synchronization of stimulus-
evoked gamma oscillations within the visual cortex is
disrupted in schizophrenia. A subsequent study con-
firmed these findings and also demonstrated that the
degree of phase locking of the occipital GBR phase
locked to reaction time is positively related to the severity
of clinical symptoms, in particular visual hallucinations,
thought disorder, and disorganization.
178
Arecentstudyobservedthatvisual-inducedGBRs,but
not evoked GBRs, are disrupted in schizophrenia
patients.
179Anotherstudy,however,foundthatvisual-in-
duced GBRs during a Gestalt perception task are not ab-
normal in schizophrenia patients.
180 Instead, this study
foundthatthesynchronizationofoscillationsinthelower,
beta frequency range is reduced and accompanies perfor-
mance deficits in schizophrenia patients. While the basis
for the discrepancy between results remains to be eluci-
dated,thesefindingsunderlinetheimportanceofassessing
both evoked and induced variants of oscillatory neuronal
responses in multiple frequency bands in schizophrenia.
Finally,abnormalitiesofevokedandinducedGBRsdo
not appear to be diagnostically specific to schizophrenia
but can be found in several other psychiatric and neuro-
logicaldisorders,includingattention-deficithyperactivity
disorder, autism, epilepsy, and Alzheimer’s disease.
152,159
Conclusion. Several studies have reported abnormali-
ties in the enhancement and phase synchronization of
GBRs during various types of sensory and cognitive in-
formation processing in schizophrenia patients. These
results provide supporting evidence for the view that neu-
ral synchrony is disrupted in schizophrenia. GBR alter-
ationsinschizophrenia,however,arenotinvariantacross
studies but seem to vary as a function of stimulus and
task-specificfactorsandpatientsamplecharacteristics,
152
includingthetypeofantipsychoticmedicationbeingused
by patients
170 and the nature and severity of their current
clinical symptoms.
159,169,174–176,178 Accordingly, al-
though the study of GBRs in schizophrenia is relatively
recent, the currently available data seem to suggest that
GBR abnormalities represent a clinical state marker,
rather than a trait marker, of schizophrenia.
An intriguing finding is the observed relationship in
schizophrenia patients between sensory-evoked GBRs
and the severity of clinical positive symptoms, particu-
larly hallucinations.
159,169,174–176,178 These data suggest
that GBRs could provide important theoretical insights
intothegenerativebrainmechanismsthatgiverisetoper-
ceptualdisturbances and hallucinationsin schizophrenia.
Correspondingly, it has been hypothesized that the cor-
relations between enlarged GBRs and hallucinations in
schizophrenia reflect cortical hyperexcitability and ab-
normally increased neural synchrony of thalamocortical
networks, leading to incoherent or ‘‘underconstrained’’
perception and disturbed conscious experience.
147,176,181
ItremainstobedeterminedwhethertheobservedGBR
abnormalities in schizophrenia reflect disrupted local or
within-area temporal synchronization or large-scale or
between-area synchronization because the underlying
bioelectrical generating sources of these abnormalities
cannot be directly inferred and visualized, but only indi-
rectly estimated, on the basis of scalp EEG data alone.
The observations that early sensory-evoked, presumably
locally generated, GBRs are often preserved in schizo-
phrenia,
172–174,179 as well as the finding of reduced syn-
chronization of beta rather than gamma oscillations in
schizophreniapatients
180seem tofavortheinterpretation
that impaired long-range functional coordination of
neuronal activation is basic to the pathophysiology
and cognitive dysfunction of schizophrenia. Important
goals for future EEG studies are the characterization
of large-scale integration of brain activity and the assess-
ment of dynamic relationships between neuronal oscilla-
tions in different frequency bands during information
processing in schizophrenia.
Additionally, the pathophysiological significance of
GBR abnormalities in schizophrenia has not yet empir-
ically been established. Basic neuroscience studies indi-
cate that networks of GABAergic interneurons and
glutamatergic pyramidal cells are critically involved
in synchronizing cortical gamma activities.
153,162,163
Accordingly, it may be hypothesized that scalp GBR
abnormalities in schizophrenia reflect altered chemical
transmission and/or electrical coupling within such
oscillating interneuronal networks, in line with current
theories that implicate disrupted GABA as well as
963
EEG in Schizophreniaglutamate/NMDA neurotransmission in the pathophys-
iology and cognitive dysfunction of schizophre-
nia.
87,88,132,133,182 Yet, to substantiate the putative role
of GABAergic mechanisms in GBR abnormalities in
schizophrenia, clinical studies are required that demon-
stratesystematiceffectsoftherapeutictreatmentinterven-
tionstargetedontheseunderlyingcellularmechanismson
the production of GBRs in schizophrenia patients.
Unresolved Issues and Future Directions
ThemainthrustofthisarticleisthatERPsandEROscan
offer valuable biological markers of basic pathophysio-
logical mechanisms and cognitive dysfunctions in schizo-
phrenia, even though they may not be specific to current
psychiatry’s diagnosis and classification. These quantita-
tive biological markers can provide unique information
on the nature and extent of cognitive and brain dys-
function in schizophrenia. Moreover, they could play
a critically helpful role in the development of effective
therapeutic treatment interventions that are focused on
specific pathophysiological mechanisms and cognitive
dysfunctions rather than on the clinical symptoms of
schizophrenia. Also, evidence is emerging that they can
be useful as an intermediate phenotype
24 in identifying
clinically unaffected and affected vulnerability-gene car-
riers
26,67 and, hence, facilitating the genetic dissection of
complex psychiatric disorders,
92 including schizophrenia
and alcoholism and related disorders. Notwithstanding,
several important methodological, conceptual, and inter-
pretative issues remain to be addressed if further progress
is to be made in this research field.
Initially,aresearcherinterestedinexaminingERPsand
EROs in schizophrenia is confronted by numerous, par-
tially arbitrary, choices related to experimental design
and paradigm (eg, passive vs active paradigm, stimulus
characteristics),dataacquisition(eg,filtercharacteristics,
reference location), data processing (eg, artifact control),
dataanalysis(eg,Fourier-basedvswaveletanalysis),data
quantification, and statistical analysis (eg, univariate vs
multivariate). Different choices may produce different,
orworse,conflictingstudyfindingsandconclusions.For-
tunately,atleastfortherecordingofcognitiveERPs
183and
multiresolution wavelet decomposition of ERPs,
184 re-
cording guidelines and analysis protocols have recently
been published that may help to resolve this problem.
An additional methodological source of variance is
that electrophysiological abnormalities in schizophrenia
are usually not invariant across studies and patient sam-
ples butthat theycanbe moderatedbystimulus and task-
specific variables (eg, stimulus properties, task difficulty,
or novelty) and subject sample characteristics (eg, clinical
symptom severity, medication status, smoking, and drug
use), including basic personal variables as age and
sex.
19,152 While the variance associated with such ‘‘mod-
erator’’ variables
185 should be carefully controlled in
patient-control group comparisons, assessing and under-
standing their moderating effects are also conceptually
important because these variables may specify the appro-
priate external and internal conditions under which, or
the subpopulations in which, the cognitive dysfunction
and pathophysiology of schizophrenia are most reliably
be expressed in a certain event-related EEG signal.
Furthermore, the anatomical substrates and functional
role in brain information processing of some event-
related EEG signals (eg, MMN) are fairly well known,
but many scalp EEG signals (eg, P300) are complex and,
thus far, not so well understood, which limits the inter-
pretation of observed alterations in these signals in schizo-
phrenia.Detailedtopographicstudies,utilizingtheoretically
and empirically well-founded experimental paradigms, ad-
vancedsignaldecomposition,spatialenhancing,andsignal-
modelingtechniques, and MRI-based anatomical informa-
tionarerequiredifmorespecificanatomical,functional,and
cognitive interpretations of scalp EEG abnormalities are to
bemadeinschizophreniaresearch.
2–7,9,10,142Onepromising
approach istoutilizealso functional neuroimagingormag-
netoencephalography data collected from the same study
participants using identical or similar experimental para-
digms
2–6,186inanattempttodelineatetheprecisebrainpro-
cesses and structures that underlie scalp-recorded EEG
abnormalities in schizophrenia.
Additionally, it is commonly assumed that ERPs and
EROs as potential endophenotypes are simpler and more
amenable to genetic dissection than the complex overt
phenotype associated with the clinical psychiatric disease
status itself, but the database on the genetic, environmen-
tal, and epigenetic factors that mediate human event-
related EEG signals is growing but is, as yet, relatively
small. Also, it seems that different event-related EEG sig-
nals, such as P300, MMN, and GBR, reflect biologically
and cognitively distinct brain mechanisms and, hence,
could reflect distinct pathophysiological mechanisms
andcognitivedysfunctionsinschizophrenia,butevidence
that each of the markers is also mediated by a partially
distinct set of genes has only recently been reported.
187
Moreover, a number of EEG abnormalities have been
observed cross-sectionally in the initial and later stages
of schizophrenia, but whether these abnormalities are
primary and causal or merely a correlate or secondary
phenomenon accompanying the clinical illness remain
to be determined. For eg, if the P300 truly reflects a vul-
nerability marker, then psychological or pharmacologi-
cal therapeutic interventions that succeed in modifying
the P300 in high-risk populations should have a modify-
ing effect on the incidence of later psychopathology in
these populations. By contrast, if the P300 merely reflects
a correlate or risk factor, then interventions should not
make a difference in outcome. Longitudinal prospective
studies are urgently needed to assess the timing, severity,
and etiologicalvalidityof electrophysiological abnormal-
ities across the subject’s lifespan and illness.
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O. van der Stelt and A. BelgerFurthermore, assuming that schizophrenia is a clini-
cally and etiologically heterogeneous disorder,
37,155,188
and given the imperfection of current psychiatric diag-
nosticsystemstocapturethisheterogeneity,family-based
high-risk studies should incorporate large subject sample
sizes and effective research strategies in which both
schizophreniapatientsandtheirunaffectedbiologicalrel-
atives are characterized in terms of both the putative vul-
nerability marker and the clinical disorder because the
relatives of patients without the marker may not be at
high risk for developing the subtype of the disorder
that is associated with the marker under investigation.
37
Finally, further studies are needed that evaluate the
empiricalrelationshipsamongdifferentEEGabnormalities
inschizophrenia
54,63andtherelationshipsoftheindividual
EEG abnormalities to neuroimaging, neurocognitive, bio-
chemical, and molecular genetic data obtained from the
samesubjects.
59,67Becauseeachresearchmethodandtech-
niquehasitsownstrengthsandlimitations,aswellasoffer-
ing a different but complementary level of description and
analysis of schizophrenia pathology, studies utilizing the
EEGinconjunctionwithotherresearchtoolswillultimately
lead to a more comprehensive description and better un-
derstanding of the cognitive and brain functions that are
altered in schizophrenia.
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